Netherlands· NL-924d08ac4388

Dogmatil 400, tabletten 400 mg

A sulpiride product containing sulpiride, registered in Netherlands by Neuraxpharm Netherlands B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC N05AL01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sulpirideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sulpiride is registered in 12 of 19 countries.

Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search sulpiride products by name

Sulpiride · ATC N05AL01

12 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulpiride costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sulpiride · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

CH Switzerland$3.83
FR France$1.00

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SULPIRIDE
Manufacturer: Neuraxpharm Netherlands B.V.
Country: Netherlands (NL)
ATC code: N05AL01
ATC class: Sulpiride
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
19811

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

23 interactions on record for sulpiride.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sulpiride against other medicines How interaction checks work

Sulpiride · interactions on record

23 records

23 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sulpiride in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulpiride products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Dogmatil, Sulpirid Grindeks
Belgium · Dogmatil, Sulpiride Eg
Cyprus · Devodil, Sulpiren
Czechia · Dogmatil, Prosulpin
Germany · Dogmatil, Dogmatil Forte
Estonia · Betamaks
Spain · Dogmatil, Dogmatil Fuerte
Finland · Suprium
France · Dogmatil, Dogmatil Sans Sucre, Édulcorée Au Cyclamate De Sodium
United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
Greece · Dogmatyl
Croatia · Eglonyl, Eglonyl Forte
Hungary · Depral
Ireland · Dolmatil
Italy · Dobren
Lithuania · Eglonyl
Luxembourg · Dogmatil, Sulpiride Eg
Latvia · Betamaks
Malta · Devodil, Sulpiride Grindeks
Poland · Sulpiryd Hasco, Sulpiryd Teva
Portugal · Dogmatil, Dogmatil Forte
Romania · Eglonyl
Slovenia · Eglonyl
Slovakia · Betamaks, Sulpirid Belupo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d4bfb73e-76ac-4cb1-b12e-59c2dd19a10c
GET /v1/drugs/d4bfb73e-76ac-4cb1-b12e-59c2dd19a10c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h19811_smpc.pdf",
  "strength": null,
  "atc_label": "Sulpiride",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg19811",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOLSTEARAAT, TYPE I",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SULPIRIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h19811.pdf",
  "authorised_at": "1996/09/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "19811",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sulpiride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console